| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 124, 2991-2994, Copyright © 1989 by Endocrine Society
ARTICLES |
M Noda and JJ Camilliere
Department of Bone Biology and Osteoporosis Research, Merck, Sharp, and Dohme Research Laboratories, West Point, Pennsylvania 19486.
The effect of transforming growth factor-beta (TGF beta) on bone in vivo was examined. Twelve daily injections of 1 microgram TGF beta directly onto the periostea of parietal bones of neonatal rats stimulated the formation of periosteal woven bone. The thickness of the treated parietal bones increased at least 2-fold in a dose-dependent manner. This TGF beta effect was localized at the sites of injection, and no change was observed in contralateral parietal bones and tibiae. The body weight in these growing rats was not affected by TGF beta 1. TGF beta 2 had effects similar to those of TGF beta 1 on the parietal bones in vivo. These results reveal for the first time that TGF beta stimulates bone formation in vivo and indicate its anabolic role in local bone metabolism.
This article has been cited by other articles:
![]() |
M. Yamashita, F. Otsuka, T. Mukai, H. Otani, K. Inagaki, T. Miyoshi, J. Goto, M. Yamamura, and H. Makino Simvastatin antagonizes tumor necrosis factor-{alpha} inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway J. Endocrinol., March 1, 2008; 196(3): 601 - 613. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Thys, I. Schrauwen, K. Vanderstraeten, K. Janssens, N. Dieltjens, K. Van Den Bogaert, E. Fransen, W. Chen, M. Ealy, M. Claustres, et al. The coding polymorphism T263I in TGF-{beta}1 is associated with otosclerosis in two independent populations Hum. Mol. Genet., September 1, 2007; 16(17): 2021 - 2030. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Tan, T. Weng, J. Zhang, J. Wang, W. Li, H. Wan, Y. Lan, X. Cheng, N. Hou, H. Liu, et al. Smad4 is required for maintaining normal murine postnatal bone homeostasis J. Cell Sci., July 1, 2007; 120(13): 2162 - 2170. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Quinlan, R. W. G. Watson, G. Kelly, P. M. Kelly, J. M. O'Byrne, and J. M. Fitzpatrick Transforming growth factor-beta (TGF-{beta}) in acute injuries of the spinal cord J Bone Joint Surg Br, March 1, 2006; 88-B(3): 406 - 410. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Janssens, P. ten Dijke, S. Janssens, and W. Van Hul Transforming Growth Factor-{beta}1 to the Bone Endocr. Rev., October 1, 2005; 26(6): 743 - 774. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-F. Iu, H. Kaji, H. Sowa, J. Naito, T. Sugimoto, and K. Chihara Dexamethasone suppresses Smad3 pathway in osteoblastic cells J. Endocrinol., April 1, 2005; 185(1): 131 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Morinobu, T. Nakamoto, K. Hino, K. Tsuji, Z.-J. Shen, K. Nakashima, A. Nifuji, H. Yamamoto, H. Hirai, and M. Noda The nucleocytoplasmic shuttling protein CIZ reduces adult bone mass by inhibiting bone morphogenetic protein-induced bone formation J. Exp. Med., March 21, 2005; 201(6): 961 - 970. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Mukudai, S. Kubota, T. Eguchi, S. Kondo, K. Nakao, and M. Takigawa Regulation of Chicken ccn2 Gene by Interaction between RNA cis-Element and Putative trans-Factor during Differentiation of Chondrocytes J. Biol. Chem., February 4, 2005; 280(5): 3166 - 3177. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Jaakkola, A. M. Crane, K. Laiho, I. Herzberg, A.-M. Sims, L. Bradbury, A. Calin, S. Brophy, M. Kauppi, K. Kaarela, et al. The effect of transforming growth factor {beta}1 gene polymorphisms in ankylosing spondylitis Rheumatology, January 1, 2004; 43(1): 32 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sowa, H. Kaji, M. F. Iu, T. Tsukamoto, T. Sugimoto, and K. Chihara Parathyroid Hormone-Smad3 Axis Exerts Anti-apoptotic Action and Augments Anabolic Action of Transforming Growth Factor {beta} in Osteoblasts J. Biol. Chem., December 26, 2003; 278(52): 52240 - 52252. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Cheng, W. Jiang, F. M. Phillips, R. C. Haydon, Y. Peng, L. Zhou, H. H. Luu, N. An, B. Breyer, P. Vanichakarn, et al. Osteogenic Activity of the Fourteen Types of Human Bone Morphogenetic Proteins (BMPs) J. Bone Joint Surg. Am., August 1, 2003; 85(8): 1544 - 1552. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Chagraoui, M. Tulliez, T. Smayra, E. Komura, S. Giraudier, T. Yun, N. Lassau, W. Vainchenker, and F. Wendling Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO Blood, April 15, 2003; 101(8): 2983 - 2989. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Janssens, P. ten Dijke, S. H. Ralston, C. Bergmann, and W. Van Hul Transforming Growth Factor-beta 1 Mutations in Camurati-Engelmann Disease Lead to Increased Signaling by Altering either Activation or Secretion of the Mutant Protein J. Biol. Chem., February 21, 2003; 278(9): 7718 - 7724. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Maeda, T. Kawane, and N. Horiuchi Statins Augment Vascular Endothelial Growth Factor Expression in Osteoblastic Cells via Inhibition of Protein Prenylation Endocrinology, February 1, 2003; 144(2): 681 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Janssens and W. Van Hul Molecular genetics of too much bone Hum. Mol. Genet., October 1, 2002; 11(20): 2385 - 2393. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sowa, H. Kaji, T. Yamaguchi, T. Sugimoto, and K. Chihara Activations of ERK1/2 and JNK by Transforming Growth Factor beta Negatively Regulate Smad3-induced Alkaline Phosphatase Activity and Mineralization in Mouse Osteoblastic Cells J. Biol. Chem., September 20, 2002; 277(39): 36024 - 36031. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Lieberman, A. Daluiski, and T. A. Einhorn The Role of Growth Factors in the Repair of Bone : Biology and Clinical Applications J. Bone Joint Surg. Am., June 1, 2002; 84(6): 1032 - 1044. [Full Text] [PDF] |
||||
![]() |
C.-F. Lai and S.-L. Cheng Signal Transductions Induced by Bone Morphogenetic Protein-2 and Transforming Growth Factor-beta in Normal Human Osteoblastic Cells J. Biol. Chem., May 3, 2002; 277(18): 15514 - 15522. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Miyakoshi, X. Qin, Y. Kasukawa, C. Richman, A. K. Srivastava, D. J. Baylink, and S. Mohan Systemic Administration of Insulin-Like Growth Factor (IGF)-Binding Protein-4 (IGFBP-4) Increases Bone Formation Parameters in Mice by Increasing IGF Bioavailability via an IGFBP-4 Protease-Dependent Mechanism Endocrinology, June 1, 2001; 142(6): 2641 - 2648. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lu, M. J. Yaszemski, and A. G. Mikos TGF-{beta}1 Release from Biodegradable Polymer Microparticles: Its Effects on Marrow Stromal Osteoblast Function J. Bone Joint Surg. Am., April 1, 2001; 83(90010): S82 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lu, M. J. Yaszemski, and A. G. Mikos TGF-{beta}1 Release from Biodegradable Polymer Microparticles: Its Effects on Marrow Stromal Osteoblast Function J. Bone Joint Surg. Am., April 1, 2001; 83(1_suppl_2): S82 - S92. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Compston Sex Steroids and Bone Physiol Rev, January 1, 2001; 81(1): 419 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Fuller, J. Lean, K. Bayley, M. Wani, and T. Chambers A role for TGFbeta(1) in osteoclast differentiation and survival J. Cell Sci., January 7, 2000; 113(13): 2445 - 2453. [Abstract] [PDF] |
||||
![]() |
T. Nakanishi, T. Nishida, T. Shimo, K. Kobayashi, T. Kubo, T. Tamatani, K. Tezuka, and M. Takigawa Effects of CTGF/Hcs24, a Product of a Hypertrophic Chondrocyte-Specific Gene, on the Proliferation and Differentiation of Chondrocytes in Culture Endocrinology, January 1, 2000; 141(1): 264 - 273. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Miyakoshi, C. Richman, X. Qin, D. J. Baylink, and S. Mohan Effects of Recombinant Insulin-Like Growth Factor-Binding Protein-4 on Bone Formation Parameters in Mice Endocrinology, December 1, 1999; 140(12): 5719 - 5728. [Abstract] [Full Text] |
||||
![]() |
J. D. HECKMAN, W. EHLER, B. P. BROOKS, T. B. AUFDEMORTE, C. H. LOHMANN, T. MORGAN, and B. D. BOYAN Bone Morphogenetic Protein But Not Transforming Growth Factor-{beta} Enchances Bone Formation in Canine Diaphyseal Nonunions Implanted with a Biodegradable Composite Polymer*{{dagger}} J. Bone Joint Surg. Am., December 1, 1999; 81(12): 1717 - 29. [Abstract] [Full Text] |
||||
![]() |
K. Notoya, H. Nagai, T. Oda, M. Gotoh, T. Hoshino, H. Muranishi, S. Taketomi, T. Sohda, and H. Makino Enhancement of Osteogenesis In Vitro and In Vivo by a Novel Osteoblast Differentiation Promoting Compound, TAK-778 J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1054 - 1064. [Abstract] [Full Text] |
||||
![]() |
H. Takai, M. Kanematsu, K. Yano, E. Tsuda, K. Higashio, K. Ikeda, K. Watanabe, and Y. Yamada Transforming Growth Factor-beta Stimulates the Production of Osteoprotegerin/Osteoclastogenesis Inhibitory Factor by Bone Marrow Stromal Cells J. Biol. Chem., October 16, 1998; 273(42): 27091 - 27096. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Erlebacher, E. H. Filvaroff, J.-Q. Ye, and R. Derynck Osteoblastic Responses to TGF-beta during Bone Remodeling Mol. Biol. Cell, July 1, 1998; 9(7): 1903 - 1918. [Abstract] [Full Text] |
||||
![]() |
T. A. Guise and G. R. Mundy Cancer and Bone Endocr. Rev., February 1, 1998; 19(1): 18 - 54. [Abstract] [Full Text] |
||||
![]() |
S.-i. Harada, T. K. Sampath, J. E. Aubin, and G. A. Rodan Osteogenic Protein-1 Up-Regulation of the Collagen X Promoter Activity Is Mediated by a MEF-2-Like Sequence and Requires an Adjacent AP-1 Sequence Mol. Endocrinol., November 1, 1997; 11(12): 1832 - 1845. [Abstract] [Full Text] |
||||
![]() |
T. Wakikawa, A. Shioi, M. Hino, M. Inaba, Y. Nishizawa, N. Tatsumi, H. Morii, and S. Otani Thrombopoietin Inhibits in Vitro Osteoclastogenesis from Murine Bone Marrow Cells Endocrinology, October 1, 1997; 138(10): 4160 - 4166. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Murakami, A. Nifuji, and M. Noda Expression of Indian Hedgehog in Osteoblasts and Its Posttranscriptional Regulation by Transforming Growth Factor-{beta} Endocrinology, May 1, 1997; 138(5): 1972 - 1978. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F. Bonewald, R. O. C. Oreffo, C. H. Lee, S. Park-Snyder, D. Twardzik, and G. R. Mundy Effects of Retinol on Activation of Latent Transforming Growth Factor-{beta} by Isolated Osteoclasts Endocrinology, February 1, 1997; 138(2): 657 - 666. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. TRIPPEL, R. D. COUTTS, T. A. EINHORN, G. R. MUNDY, and R. G. ROSENFELD Instructional Course Lectures, The American Academy of Orthopaedic Surgeons - Growth Factors as Therapeutic Agents*{{dagger}} J. Bone Joint Surg. Am., August 1, 1996; 78(8): 1272 - 86. [Full Text] |
||||
![]() |
Y. Takeuchi, K. Nakayama, and T. Matsumoto Differentiation and Cell Surface Expression of Transforming Growth Factor-beta Receptors Are Regulated by Interaction with Matrix Collagen in Murine Osteoblastic Cells J. Biol. Chem., February 16, 1996; 271(7): 3938 - 3944. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Riikonen, L. Koivisto, P. Vihinen, and J. Heino Transforming Growth Factor-beta Regulates Collagen Gel Contraction by Increasing alpha2beta1 Integrin Expression in Osteogenic Cells J. Biol. Chem., January 6, 1995; 270(1): 376 - 382. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Critchlow, Y. Bland, and D. Ashhurst The effects of age on the response of rabbit periosteal osteoprogenitor cells to exogenous transforming growth factor-beta 2 J. Cell Sci., January 2, 1994; 107(2): 499 - 516. [Abstract] [PDF] |
||||
![]() |
R Langer and J. Vacanti Tissue engineering Science, May 14, 1993; 260(5110): 920 - 926. [Abstract] [PDF] |
||||
![]() |
C.-F. Lai, X. Feng, R. Nishimura, S. L. Teitelbaum, L. V. Avioli, F. P. Ross, and S.-L. Cheng Transforming Growth Factor-beta Up-regulates the beta 5 Integrin Subunit Expression via Sp1 and Smad Signaling J. Biol. Chem., November 10, 2000; 275(46): 36400 - 36406. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Gu and S. J. Publicover Expression of Functional Metabotropic Glutamate Receptors in Primary Cultured Rat Osteoblasts. CROSS-TALK WITH N-METHYL-D-ASPARTATE RECEPTORS J. Biol. Chem., October 27, 2000; 275(44): 34252 - 34259. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Shi, S. Bai, L. Li, and X. Cao Hoxa-9 Represses Transforming Growth Factor-beta -induced Osteopontin Gene Transcription J. Biol. Chem., January 5, 2001; 276(1): 850 - 855. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |